首页> 外文会议>International Symposium on Hormonal Carcinogenesis >Bi-directional Regulation of Human Progesterone Receptors and the Mitogen Activated Protein Kinase Pathway in Breast Cancer Cell Models
【24h】

Bi-directional Regulation of Human Progesterone Receptors and the Mitogen Activated Protein Kinase Pathway in Breast Cancer Cell Models

机译:人孕酮受体的双向调节和乳腺癌细胞模型中的促丝瘤活性蛋白激酶途径

获取原文

摘要

Breast cancers (BCs) often have increased mitogen-activated protein kinase (MAPK) activity. This pathway influences BC cell growth in part by targeting steroid hormone receptors. Activation of p42 and p44 MAPKs increases progesterone receptor (PR) transcriptional activity in the presence of progestins, and triggers their rapid down-regulation by the ubiquitin-proteasome pathway. In turn, progestins increase the expression of type I growth factor receptor tyrosine kinases that feed into MAPK activation. Recently, progestins have been shown to activate the p42/p44 MAPK module in a PR-dependent manner, but independently of their function as transcription factors. Mechanisms of bi-directional cross-talk between these two pathways are becoming well-documented. Herein, we provide an overview of the primary ways in which steroid hormone receptor and growth factor cross-talk occurs, using examples from our work with human PR as a model receptor; we demonstrate MAPK regulation of PR subcellular localization, transcriptional synergy, and regulation of cyclin D1 expression. Cross-talk between growth factor and PR-mediated signaling events is an important means by which growth regulatory genes are coordinately regulated, and may contribute to the growth of hormonally responsive normal breast tissue and to BC.
机译:乳腺癌(BCS)通常具有升高的丝裂原激活蛋白激酶(MAPK)活性。该途径通过靶向类固醇激素受体来影响BC细胞生长。 P42和P44 MAPK的激活增加了孕激素存在下的孕酮受体(PR)转录活性,并触发其通过泛素 - 蛋白酶体途径的快速下调。反过来,progestins增加了I型生长因子受体酪氨酸激酶的表达,其进料到MAPK活化。最近,已显示孕激素以PR相关的方式激活P42 / P44 MAPK模块,但独立于它们作为转录因子的功能。这两种途径之间的双向交叉谈话的机制变得良好。在此,我们概述了类固醇激素受体和生长因子串扰发生的主要方式,使用我们与人道的实例作为模型受体;我们展示了PRA亚细胞定位,转录协同作用和细胞周期蛋白D1表达的调节。生长因子和PR介导的信号事件之间的串扰是生长调节基因协调的重要方法,并且可能有助于激素响应常规乳腺组织和BC的生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号